Yale University Study on COVID Post-Vaccination Syndrome
Segment # 386
Here is some additional data on the COVID vaccines. The medical community is having a hard time ignoring the obvious problems that are reflected in fact based research. It’s a start
Yale University Study on COVID Post-Vaccination Syndrome
Published On: March 6, 2025
Speakers: Dr. Joseph Varon, Dr. Ryan Cole, Dr. Kirk Milhoan, Dr. Lynn Fynn
A new study from Yale has uncovered alarming findings: the spike protein from COVID-19 vaccines can persist in the body for over two years—much longer than previously measured. Even more concerning, researchers suggest that many cases of so-called long COVID may actually be post-vaccination syndrome (PVS), a condition caused by lingering vaccine-induced spike protein.
IMA President & Chief Medical Officer Dr. Joseph Varon leads an expert panel featuring IMA Senior Fellows Dr. Ryan Cole and Dr. Kirk Milhoan, along with researcher Dr. Lynn Fynn to break down the study, its implications, and what it means for those suffering from PVS. They’ll explore how vaccine persistence affects the immune system, the overlap between PVS and long COVID, and the growing body of research on post-vaccine health concerns. Don’t miss this vital conversation with top medical experts on the front lines of patient care and scientific inquiry.
“When I saw [The Yale Study], it validated what we’ve been fighting for the last several years” – Dr. Joseph Varon, IMA President & Chief Medical Officer
For years, our organization has sounded the alarm on the dangers of the COVID-19 injections. These so-called “vaccines” were launched with a chorus of headlines declaring them “97% safe and effective.” The initial rollout seemed straightforward—elderly and vulnerable populations would receive access first, followed by the rest of the public.
But as 2021 unfolded, fear and the promise of “getting back to normal” drove many to vaccinate who may have otherwise hesitated. That still wasn’t enough. Soon came the mandates: Want to keep your job? Get the jab. Want to go to school? You know what to do.
Before long, vaccination was required for nearly every aspect of life. And with that level of pressure, one would assume these injections were rock solid in terms of both efficacy and safety. Catastrophically, that couldn’t have been further from the truth. Alarming safety signals began to emerge, revealing the COVID-19 “vaccines” as the deadliest in history. In fact, the number of injuries reported surpassed those of all other vaccines combined over the past 20+ years.
For those paying attention, the dangers were obvious. Independent researchers and frontline clinicians began confirming the safety signals. Under normal circumstances, a medical product with even a fraction of these issues would have been pulled from the market. But these were not normal circumstances. What followed was one of the greatest medical disasters in human history.
Fast forward to today: millions of vaccine-injured and grieving families still await justice. A shot that failed to prevent infection and has caused untold harm remained unquestioned by mainstream science—until now. Finally, researchers at Yale have published a study that formally connects the dots between the COVID injections and the many adverse effects reported by victims. They’ve labeled the condition “Post-Vaccination Syndrome” (PVS) and make it clear: this is distinct from long COVID.
For those who saw the warning signs early on, the study is a bittersweet validation. But what exactly does it say? And, perhaps more importantly, what does it still fail to acknowledge? Our experts break it all down.
Press play on the webinar above, or keep scrolling for the key takeaways.
What Are the Key Findings in the New Yale Study?
As many are aware by now, this is not the first study to link the COVID-19 injections to bad outcomes. But nevertheless, researchers at Yale University have formally acknowledged what many independent doctors and researchers have been warning about for years—Post-Vaccination Syndrome (PVS) is real.
For scientists and patients, it’s a strong validation of what they knew was true from the start. Looking at 42 individuals with PVS, and comparing them to 22 healthy controls, what they found confirms the worst fears of those who have been following vaccine safety signals.
While the Yale study marks an important milestone in recognizing Post-Vaccination Syndrome, it leaves critical questions unanswered. Our panel of experts—Dr. Joseph Varon, Dr. Ryan Cole, Dr. Kirk Milhoan, and Dr. Lynn Fynn—break down what the study confirms, what it misses, and what’s still desperately needed in vaccine injury research.
The Study Confirms What Frontline Doctors Have Seen for Years
The Yale researchers’ findings align closely with what clinicians have observed in thousands of vaccine-injured patients:
Persistent Spike Protein: Detection of spike protein up to 709 days post-vaccination corroborates real-world reports that mRNA-induced spike production lingers far longer than initially claimed.
Immune System Dysfunction: The study confirms CD4 depletion, CD8 elevation, and dendritic cell suppression, a pattern of immune dysregulation consistent with clinical observations.
Viral Reactivations: Physicians treating vaccine-injured patients have consistently reported Epstein-Barr virus (EBV), a phenomenon now acknowledged in the Yale research.
Neurological & Autoimmune Links: Findings of autoantibodies and neurological symptoms mirror countless case reports from frontline doctors.
While these findings are refreshing to see in a Yale-backed publication, there are many omissions outstanding. For example, while the study shows up to 709 days of spike protein production in vaccine recipients, we don’t have any idea when the average person stops producing it:
“Even this study shows up to 709 days [of spike protein production], we still don’t know how long because there’s still no good study showing what the actual cut-off is.” – Dr. Ryan Cole
Key Omissions: What the Study Fails to Address
“The first sentence in the study literally says, ‘millions of lives were saved by the vaccines.’ It’s like you must kiss the ring to get published.” – Dr. Lynn Fynn
The scientific landscape might be slowly changing, but it’s still got a long way to go. Despite its significance, the study has glaring weaknesses too:
No Unvaccinated Control Group: The research only compared PVS patients to vaccinated individuals who “felt healthy.” Without an unvaccinated comparison, it fails to establish how much of this damage is vaccine-specific versus post-COVID effects.
Downplaying Severe Outcomes: The study acknowledges symptoms but doesn’t quantify the full scope of disability, life-threatening complications, or deaths related to PVS.
Limited Scope of Viral Reactivation: EBV was studied, but doctors report widespread reactivation of shingles, herpes, cytomegalovirus (CMV), and other latent infections—a factor left out of the research, as Dr. Fynn rightly points out.
Selection Bias? The dataset used originated from an app where vaccine-injured individuals submitted symptoms. Questions remain about how subjects were chosen and whether critical data points were excluded.
Moreover, as Dr. Kirk Milhoan stresses, there are yet more potential injuries across a wide range of patients. As a pediatric cardiologist, he’s seen the impact of the COVID-19 injections to children:
“I’m seeing what I call an epidemic of dysautonomia. Kids coming in with inappropriate sinus tachycardia, sitting down doing nothing, and their heart is racing.”
Dr. Milhoan continues:
“This spike protein is going through all the same pathways that I studied in myocardial inflammation. Once it gets to the endothelial cells, it sets off a whole cascade of issues.”
These kinds of observations make it clear: we aren’t out of the woods yet.
The Bigger Picture: What This Means for the Vaccine-Injured
“Every university in the country should be doing this type of research. This is at least an entree into the fact that, look, it’s doable. These universities should have our backs now.” – Dr. Ryan Cole
For the millions suffering from vaccine injuries, this study is both a victory and a warning. On one hand, a major academic institution is finally admitting that PVS exists. On the other, the study’s limitations and cautious framing suggest that mainstream science is still reluctant to fully expose the scale of vaccine harm.
Learn more:
Our experts agree: this is only the beginning. The Yale study lays the groundwork, but more comprehensive, independent research—free from pharmaceutical influence—is needed to uncover the full extent of vaccine-induced disease and, more importantly, how to treat it.
“There are too many injured out there getting no help, and until we stop saying ‘this is extremely rare,’ we can’t move forward. We have to acknowledge the scale of this.” – Dr. Lynn Fynn
The road ahead demands rigorous, uncompromised medical research—free from the influence of pharmaceutical giants and institutions more concerned with protecting narratives than uncovering the truth. That’s why the Independent Medical Alliance launched the Journal of Independent Medicine—a new home for fearless, evidence-based inquiry. The fight for truth in medicine has only just begun.
For more webinars regarding COVID-19 injections, mRNA technology, and vaccine injury, don’t miss the following episodes:
Continue the conversation at the Forums
More on: Dr. Joseph Varon | Dr. Kirk Milhoan | Dr. Lynn Fynn | Dr. Ryan Cole | I-RECOVER Protocol | Yale Study COVID PVS